2016 Flow Cytometry Presentations

Please note: Only those presentations where permission has been received for posting are available to meeting delegates. A large number of speakers are in the process of providing ISCT with revised slides and as a result, these presentations will be gradually uploaded to the website as they are received.

Reference to these materials will be useful but not comprehensive in developing appropriate standards of care. Their use does not confer any professional qualification or standard. Publication of these materials does not constitute an endorsement of ISCT. ISCT has not reviewed these materials to ensure consistency with acceptable practices. The views expressed in these materials represent the opinion of the authors. ISCT expressly disclaims any liability arising from any inaccuracy or misstatement. Each facility and/or individual referring to these materials should analyze the information, practices and procedures outlined therein to determine their acceptability for use in the context of their own obligations and within their own facility's standards and procedures.

Speakers for the following presentations have given authorization to post their materials.

Presentations are continually being added. Please check back regularly. 


Session I
Variability & Reproducibility
Ruud Hulspas, Cytonome ST – Variability Is in the Eyes of the Beholder
John T. Elliot, National Institute of Standards and Technology (NIST) – Measurement Assurance Strategies for Flow Cytometry

Session II
Product Characterization by Flow Cytometry
Emily Blyth, Westmead Hospital – T Cell Immune Reconstitution Post Allogeneic Transplant – Product Characterization and Post Infusion Monitoring 
Alexandra Rizzitelli, Cell Therapies – Flow Cytometry Tools for Characterization of GMP Cell Products
John Connolly, Institute of Molecular and Cell Biology – High Dimensional Analysis of In-Vitro Expanded CTLs for Cancer Immune Therapy

Session III
Quality Assurance and Quality Control 
Paresh Jain, BD Biosciences – Quality Control in Flow Cytometry - The Instrument Variable 
Peter Wang, National Cancer Centre Singapore – Adopting Flow Cytometry to QC a Heterogeneous Immunotherapy Product - A Garagiste's Experience 
Edouard Bernet, Thermo Fisher Scientific – QC Quality Check for In-Process and End Point Identity Check 

Session IV
Sustainable Flow Cytometry
Agnieszka Blum, Charite Berlin, and Michael Kapinsky, Beckman Coulter Flow Cytometry – Purging High Content Flow Cytometry of Human Error Sources and Expert Operation Requirements
Ren Capocasale, FlowMetric – Accelerating Cellular Therapies Through Flow Cytometry Services 

Closing Panel Discussion
D. Robert Sutherland, University of Toronto, University Health Network/Toronto General Hospital
Ruud Hulspas, Cytonome ST
Vivek Tanavde, Bioinformatics Institute
Paul Hutchinson, National University of Singapore


© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.